Background Image
Table of Contents Table of Contents
Previous Page  4 / 74 Next Page
Information
Show Menu
Previous Page 4 / 74 Next Page
Page Background

financial & production

co-ordinator

ELSABÉ BURMEISTER

Tel: 021 976 8129

Fax: 086 664 4202

Cell: 082 775 6808

e-mail:

elsabe@clinicscardive.com

Production Editor

SHAUNA GERMISHUIZEN

Tel: 021 785 7178

Cell: 083 460 8535

e-mail:

shauna@clinicscardive.com

CONTENT MANAGER

Michael Meadon (Design

Connection)

Tel: 021 976 8129

Fax: 0866 557 149

e-mail:

michael@clinicscardive.com

GAUTENG CONTRIBUTOR

PETER WAGENAAR

Cell 082 413 9954

e-mail:

skylark65@myconnection.co.za

The

Cardiovascular Journal of Africa

,

incorporating the

Cardiovascular

Journal of South Africa

, is published 10

times a year, the publication date being

the third week of the designated month.

Copyright:

Clinics Cardive Publishing (Pty) Ltd.

Layout:

Martingraphix

Printer:

Tandym Print/Castle Graphics

ONLINE publishing & coding

SERVICES:

Design Connection &

Active-XML.com

All submissions to CVJA are to be

made online via

www.cvja.co.za

Electronic submission by means of an

e-mail attachment may be considered

under exceptional circumstances.

Postal address: PO Box 1013,

Durbanville, RSA, 7551

Tel: 021 976 8129

Fax: 0866 644 202

Int.: +27 21 976 8129

e-mail:

info@clinicscardive.com

Electronic abstracts available on Pubmed

Audited circulation

Full text articles available on: www.cvja.

co.za

or via

www.sabinet.co.za;

for access

codes contact

elsabe@clinicscardive.com

Subscriptions for 6 issues:

To subscribe to the journal or change

your postal address, e-mail

elsabe@clinicscardive.com

South Africa: R490 (incl VAT)

Overseas: $135

Online subscription: R300

The views and opinions expressed in the

articles and reviews published are those

of the authors and do not necessarily

reflect those of the editors of the Journal

or its sponsors. In all clinical instances,

medical practitioners are referred to the

product insert documentation as approved

by the relevant control authorities.

CONTENTS

Vol 29, No 5, SEPTEMBER/OCTOBER 2018

305 The impact of admission cystatin C levels on in-hospital and three-year mortality rates

in acute decompensated heart failure

H Selcuk • MT Selcuk • O Maden • KG Balci • MM Balci • S Tekeli • EH Çetin • A Temizhan

• M Balci • N Karabiber

310 The clinical prognostic significance of myocardial performance index (MPI) in stable

placental-mediated disease

I Bhorat • M Pillay • T Reddy

REVIEW ARTICLES

317 Rheumatoid arthritis and risk of cardiovascular disease

PWA Meyer • R Anderson • JA Ker • MTM Ally

322 The role of novel atherosclerosis markers in peripheral artery disease: is there a

gender difference?

H Com

ş

a • D Zdrenghea • SC Man • D Pop

PASCAR REPORT

331 Development of the certificate course in the management of hypertension in Africa

(CCMH-Africa): proceedings of the first continental faculty meeting, Nairobi, Kenya,

25–26 February 2018

A Dzudie • D Ojji • A Damasceno • MU Sani • E Kramoh • JBA Kacou • B Anisiuba • E Ogola •

M Awad • G Nel • H Otieno • AI Toure • A Kane • AP Kengne • C Ngwasiri • H Ba • S Kingue •

B Mipinda • BE Mbolla • A Weldehana • F Bukachi • B Gitura • B Kitio • B Rayner • AE Shutte •

AO Mocumbi • B Mayosi • A Jose • B Sandeep • M Weber • C Delles • F Cappuccio • H Gamra •

D Prabhakaran • N Poulter • S Subhani • on behalf of the PASCAR task force on hypertension

PUBLISHED ONLINE

(Available on

www.cvja.co.za

and in PubMed)